HRAS mutations and resistance to the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in head and neck squamous cell carcinoma cells.
about
Genomic Correlate of Exceptional Erlotinib Response in Head and Neck Squamous Cell Carcinoma.Drug-induced RAF dimerization is independent of RAS mutation status and does not lead to universal MEK dependence for cell survival in head and neck cancersIdentification of Key Genes and Pathways in Tongue Squamous Cell Carcinoma Using Bioinformatics Analysis.RAS-MAPK reactivation facilitates acquired resistance in FGFR1-amplified lung cancer and underlies a rationale for upfront FGFR-MEK blockade.Functional precision medicine identifies novel druggable targets and therapeutic options in head and neck cancer.Nuclear Klf4 accumulation is associated with cetuximab drug-resistance and predicts poor prognosis of nasopharyngeal carcinoma.
P2860
HRAS mutations and resistance to the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in head and neck squamous cell carcinoma cells.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
HRAS mutations and resistance ...... squamous cell carcinoma cells.
@ast
HRAS mutations and resistance ...... squamous cell carcinoma cells.
@en
HRAS mutations and resistance ...... squamous cell carcinoma cells.
@nl
type
label
HRAS mutations and resistance ...... squamous cell carcinoma cells.
@ast
HRAS mutations and resistance ...... squamous cell carcinoma cells.
@en
HRAS mutations and resistance ...... squamous cell carcinoma cells.
@nl
prefLabel
HRAS mutations and resistance ...... squamous cell carcinoma cells.
@ast
HRAS mutations and resistance ...... squamous cell carcinoma cells.
@en
HRAS mutations and resistance ...... squamous cell carcinoma cells.
@nl
P2093
P2860
P50
P356
P1433
P1476
HRAS mutations and resistance ...... squamous cell carcinoma cells
@en
P2093
Chad Galer
David R Fooshee
Edward Kim
Genevieve A Andrews
Jeffrey N Myers
Lauren A Byers
Mitchell J Frederick
Samar A Jasser
P2860
P304
P356
10.1002/HED.23499
P577
2014-03-20T00:00:00Z